Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | 2Fe.2O4S.3H2O |
| Molecular Weight | 357.861 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O.O.O.[Fe++].[Fe++].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O
InChI
InChIKey=JJUUPAANEJLKEY-UHFFFAOYSA-J
InChI=1S/2Fe.2H2O4S.3H2O/c;;2*1-5(2,3)4;;;/h;;2*(H2,1,2,3,4);3*1H2/q2*+2;;;;;/p-4
| Molecular Formula | O4S |
| Molecular Weight | 96.063 |
| Charge | -2 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | H2O |
| Molecular Weight | 18.0153 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | Fe |
| Molecular Weight | 55.845 |
| Charge | 2 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/14116934http://www.foodchemadditives.com/products/Ferrous-Lactatehttp://nj.gov/health/eoh/rtkweb/documents/fs/0928.pdfDOI: 10.1021/ja00949a016 Retrived from http://pubs.acs.org/doi/abs/10.1021/ja00949a016https://www.drugs.com/inactive/ferrous-oxide-389.htmlhttp://www.druglead.com/cds/ferrous-iodide.htmlhttp://www.drugfuture.com/chemdata/ferroglycine-sulfate.htmlhttps://www.ncbi.nlm.nih.gov/pubmed/16694502Curator's Comment: description was created based on several sources, including
http://www.minapharm.com/Public/ProductDetails.aspx?ProductCode=FERRO_SANO&langParam=en
Sources: https://www.ncbi.nlm.nih.gov/pubmed/14116934http://www.foodchemadditives.com/products/Ferrous-Lactatehttp://nj.gov/health/eoh/rtkweb/documents/fs/0928.pdfDOI: 10.1021/ja00949a016 Retrived from http://pubs.acs.org/doi/abs/10.1021/ja00949a016https://www.drugs.com/inactive/ferrous-oxide-389.htmlhttp://www.druglead.com/cds/ferrous-iodide.htmlhttp://www.drugfuture.com/chemdata/ferroglycine-sulfate.htmlhttps://www.ncbi.nlm.nih.gov/pubmed/16694502
Curator's Comment: description was created based on several sources, including
http://www.minapharm.com/Public/ProductDetails.aspx?ProductCode=FERRO_SANO&langParam=en
Iron(II) gluconate (also known as a ferrous gluconate) is used in the treatment of hypochromic anemia. The real problem of iron therapy is not the theoretical utilization of iron, or the reticulocyte response, or even the daily increase of hemoglobin. These are important only as they indicate the return of the patients' blood to normal in a reasonably short time without undue inconvenience. Most patients suffering from hypochromic anemia respond well to most forms of iron when administered in adequate dosage. For the patients who cannot tolerate the usual iron compounds, it is important to have a medication which is effective and which causes minimum disturbance. Ferrous gluconate is such a medicament.
Originator
Approval Year
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Palliative | Unknown Approved UseUnknown |
|||
| Palliative | Unknown Approved UseUnknown |
|||
| Primary | Ferro Sanol Duodenal Approved UseFerro Sanol is an iron substitute in case of latent or manifest iron deficiency with and without development of anaemia. |
|||
PubMed
| Title | Date | PubMed |
|---|---|---|
| THE USE OF FERROUS GLUCONATE IN THE TREATMENT OF HYPOCHROMIC ANEMIA. | 1937 Jul |
|
| [Ferrous lactate as an oral iron preparation for therapeutic use]. | 1954 Nov 27 |
|
| Clinical appraisal of drugs with special reference to a new chelate hematinic. | 1957 Jul 11 |
|
| [FERROUS ASPARTATE IN THERAPY]. | 1964 Jan 1 |
|
| Determination of water in ferrous lactate by near infrared reflectance spectroscopy with a fibre-optic probe. | 1997 Oct |
|
| Decreased treatment failure rates following duodenal release ferrous glycine sulfate in iron deficiency anemia associated with autoimmune gastritis and Helicobacter pylori gastritis. | 2007 |
|
| The effect of iron treatment on adhesion molecules in patients with iron deficiency anemia. | 2010 Dec |
|
| Tolerability of different oral iron supplements: a systematic review. | 2013 Apr |
|
| Effect of abomasal ferrous lactate infusion on phosphorus absorption in lactating dairy cows. | 2013 Jul |
|
| A practical and successful desensitization protocol for immediate hypersensitivity reactions to iron salts. | 2014 |
|
| Synthesis of phosphabenzenes by an iron-catalyzed [2+2+2] cycloaddition reaction of diynes with phosphaalkynes. | 2015 Jun 22 |
|
| Reactivity enhancement of iron sulfide nanoparticles stabilized by sodium alginate: Taking Cr (VI) removal as an example. | 2017 Jul 5 |
|
| Atomic Layer Deposition of Iron Sulfide and Its Application as a Catalyst in the Hydrogenation of Azobenzenes. | 2017 Mar 13 |
|
| Continuous sulfidogenic wastewater treatment with iron sulfide sludge oxidation and recycle. | 2017 May 1 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 08:10:34 UTC 2023
by
admin
on
Sat Dec 16 08:10:34 UTC 2023
|
| Record UNII |
1OA214846O
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
90478523
Created by
admin on Sat Dec 16 08:10:34 UTC 2023 , Edited by admin on Sat Dec 16 08:10:34 UTC 2023
|
PRIMARY | |||
|
13463-43-9
Created by
admin on Sat Dec 16 08:10:34 UTC 2023 , Edited by admin on Sat Dec 16 08:10:34 UTC 2023
|
NON-SPECIFIC STOICHIOMETRY | |||
|
SUB30109
Created by
admin on Sat Dec 16 08:10:34 UTC 2023 , Edited by admin on Sat Dec 16 08:10:34 UTC 2023
|
PRIMARY | |||
|
1OA214846O
Created by
admin on Sat Dec 16 08:10:34 UTC 2023 , Edited by admin on Sat Dec 16 08:10:34 UTC 2023
|
PRIMARY | |||
|
DBSALT002668
Created by
admin on Sat Dec 16 08:10:34 UTC 2023 , Edited by admin on Sat Dec 16 08:10:34 UTC 2023
|
PRIMARY | |||
|
100000092908
Created by
admin on Sat Dec 16 08:10:34 UTC 2023 , Edited by admin on Sat Dec 16 08:10:34 UTC 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ANHYDROUS->SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
